This discrepancy may be explained by the inflammatory background and/or iron deficiency in the oncology patient cohort (Supplemental Table 11) as well as systemic inflammation caused by the transfusion itself, culminating in high hepcidin serum concentration (2, 13, 16). Here, HAMP is linked to nutritional disorder.